Diana Alvarado v. HHS - Tdap, Guillain-Barre syndrome (GBS) and/or chronic inflammatory demyelinating polyneuropathy (CIDP) (2026)

On August 8, 2024, Diana Alvarado filed a petition alleging that influenza and Tdap vaccines administered in her left deltoid on August 22, 2023 caused Guillain-Barre syndrome, or alternatively GBS and/or chronic inflammatory demyelinating polyneuropathy. The stipulation also notes a later October 2, 2023 COVID-19 vaccination with a flu vaccine, and it addresses waiver of any CICP claim as part of the settlement.

Respondent denied that Ms. Alvarado sustained a Table GBS injury, denied that her alleged GBS, CIDP, or residual effects were caused in fact by the flu or Tdap vaccines, and denied that the vaccines caused any other injury.

The public stipulation does not describe the first neurologic symptom, hospitalization, testing, treatment, rehabilitation, or residual limitations. On January 15, 2026, Chief Special Master Brian H.

Corcoran adopted the parties' stipulation and awarded $90,693.72 through counsel's IOLTA account.